Biotech, Life Sciences, & Pharmaceuticals

Financial Compliance for Growth-Oriented Life Science Companies

Biotechnology, life science and pharmaceutical breakthroughs play an important role in the future of health care, both nationally and globally. The Gumbiner Savett (GS) life sciences team includes audit, tax and advisory professionals with years of experience in their fields, delivering strategic advice for our clients’ continued growth and success. Our team works to provide compliance, identify issues and solve problems for every type of business within these industries, including:

  • Pharmaceutical and biopharma companies
  • Medical device manufacturers
  • Biotech companies

Our professionals are well versed with accounting issues and provide solutions that get our clients to an effective result with IPO services (including IPO readiness and registration statements), audited financial statements, tax preparation and planning, as well as other compliance related services. GS also has experience with other complex transactions these companies may face as they grow including:

  • Follow-on offerings
  • R&D tax credits
  • License agreements and research arrangements
  • Share-based payments
  • Convertible debt with beneficial conversion features
  • Business combinations and asset acquisitions
  • Intellectual property capitalization and impairment
  • Accounting for funded research and development arrangements